These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15545016)

  • 41. Relation between plasma homocysteine and Alzheimer's disease.
    Nilsson K; Gustafson L; Hultberg B
    Dement Geriatr Cogn Disord; 2002; 14(1):7-12. PubMed ID: 12053126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
    Goldknopf IL; Park HR; Sabbagh M
    Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Serum Homocysteine Level with Parkinson's Disease.
    Losy SA; Saiduzzman M; Battacharjee M; Moniruzzman AHM; Bhuya MSI; Linckon MK; Banerjee S; Islam MS; Mia E
    Mymensingh Med J; 2024 Jul; 33(3):643-648. PubMed ID: 38944701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between behavioural and psychological symptoms of Alzheimer type dementia and plasma homocysteine concentration.
    Zheng Z; Wang J; Yi L; Yu H; Kong L; Cui W; Chen H; Wang C
    Biomed Res Int; 2014; 2014():383494. PubMed ID: 24995291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
    Ouanes S; Rabl M; Clark C; Kirschbaum C; Popp J
    Alzheimers Res Ther; 2022 Dec; 14(1):190. PubMed ID: 36529757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma Homocysteine and Serum Folate and Vitamin B
    Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemical and clinical effects of Whey protein supplementation in Parkinson's disease: A pilot study.
    Tosukhowong P; Boonla C; Dissayabutra T; Kaewwilai L; Muensri S; Chotipanich C; Joutsa J; Rinne J; Bhidayasiri R
    J Neurol Sci; 2016 Aug; 367():162-70. PubMed ID: 27423583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions.
    Zoccolella S; Lamberti P; Iliceto G; Diroma C; Armenise E; Defazio G; Lamberti SV; Fraddosio A; de Mari M; Livrea P
    Clin Chem Lab Med; 2005; 43(10):1107-10. PubMed ID: 16197306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients.
    Mancuso R; Agostini S; Hernis A; Zanzottera M; Bianchi A; Clerici M
    Sci Rep; 2019 Jun; 9(1):9393. PubMed ID: 31253822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cortisol and dehydroepiandosterone sulfate plasma levels and their relationship to aging, cognitive function, and dementia.
    de Bruin VM; Vieira MC; Rocha MN; Viana GS
    Brain Cogn; 2002 Nov; 50(2):316-23. PubMed ID: 12464198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
    Hernanz A; De la Fuente M; Navarro M; Frank A
    Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
    Selley ML
    Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease.
    Gold M; Hauser RA; Chen MF
    Metab Brain Dis; 1998 Mar; 13(1):43-53. PubMed ID: 9570639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients.
    Geisler J; Engelsen BA; Berntsen H; Geisler S; Lønning PE
    J Endocrinol; 1997 May; 153(2):307-12. PubMed ID: 9166121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease.
    Li J; Gu C; Zhu M; Li D; Chen L; Zhu X
    Psychogeriatrics; 2020 Mar; 20(2):180-188. PubMed ID: 31828903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma homocysteine levels are not increased in murine models of Alzheimer's disease.
    Santiard-Baron D; Aupetit J; Janel N
    Neurosci Res; 2005 Dec; 53(4):447-9. PubMed ID: 16213620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer's Disease.
    Zverova M; Kitzlerova E; Fisar Z; Jirak R; Hroudova J; Benakova H; Lelkova P; Martasek P; Raboch J
    Curr Alzheimer Res; 2018; 15(10):938-950. PubMed ID: 29852871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
    Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
    Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof].
    Liu XQ; Liu XQ; Jiang P; Huang H; Yan Y
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2246-9. PubMed ID: 19087670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.